Stifel Maintains Hold on TransMedics Group, Lowers Price Target to $85
Benzinga Newsdesk 6 months ago
NewsPrice TargetAnalyst Ratings
Stifel analyst Thomas Stephan maintains TransMedics Group (NASDAQ:TMDX) with a Hold and lowers the price target from $130 to $85.
Stifel analyst Thomas Stephan maintains TransMedics Group (NASDAQ:TMDX) with a Hold and lowers the price target from $130 to $85.